Indeed, platelet count – thrombocytopenia, particularly – and coagulation biomarkers, such as D‐dimer, prothrombin time, and fibrin degradation products are related to disease severity and disseminated intravascular coagulation, and the mechanism behind them may be the inflammatory alterations in cell composition and cytokine milieu, particularly lymphopenia, that patients with obesity affected by COVID‐19 face.141, 142, 143. This evidence concerns the gene F2 and obesity disorder.